0115 7041 (Lipram-UL 18 58500 U / 18000 U / 58500 U)
Generic Name: pancrelipase
Pill imprint 0115 7041 has been identified as Lipram-UL 18 58500 U / 18000 U / 58500 U.
Lipram-UL 18 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Lipram-UL 18 58500 U / 18000 U / 58500 U is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- pancrelipase
- Imprint:
- 0115 7041
- Strength:
- 58500 U / 18000 U / 58500 U
- Color:
- Tan & White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals
- National Drug Code (NDC):
- 00115-7041
More about Lipram-UL 18 (pancrelipase)
Consumer resources
- Other brands: Creon, Zenpep, Pancreaze, Pertzye, More (10) »
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
